A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
מצבים רפואיים
Chronic Myelomonocytic Leukemia · Chronic Myelomonocytic Leukemia (CMML) · Chronic Myelomonocytic Leukemia-1 · Chronic Myelomonocytic Leukemia-2 · Refractory Chronic Myelomonocytic Leukemia · CMML · Acute Myeloid Leukemia · Acute Myeloid Leukemia (AML) · Acute Myeloid Leukemia Post Cytotoxic Therapy · Acute Myeloid Leukemias · Refractory Acute Myeloid Leukemia (AML) · Acute Monocytic Leukemia
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Stanford University, Stanford, California, United States
Contact: Principal Investigator (Principal Investigator, MD)Moffitt, Tampa, Florida, United States
Contact: Principal Investigator (Principal Investigator, MD)DFCI, Boston, Massachusetts, United States
Contact: Principal Investigator (Principal Investigator, MD)Mayo Clinic, Rochester, Minnesota, United States
Contact: Principal Investigator (Principal Investigator, MBBS)OHSU, Portland, Oregon, United States
Contact: Principal Investigator (Principal Investigator, MD)Vanderbilt University, Nashville, Tennessee, United States
Contact: Principal Investigator (Principal Investigator, MBBS)MD Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Principal Investigator, MD)
מובילי המחקר
Chief Medical Officer, MD, MSc, MBA
Study Director
Solu Therapeutics